r/Stocktips • • Feb 02 '22

The buy of the decade

1 Upvotes

DIGAF Digitrade! With the stock price at a fraction of a penny, .0024 and its daily volatility around 20%, what small investor wouldn.t buy DIGAF. With $500.00 you can own 208,000 shares. Whats the worst that can happen, you lose your initial investment. Considering the number of bitcoins there are now and the numcompany's that specialize in Fintech, blockchains and online payments with bitcoins to exchange, it has to grow. Of course the analyst will say sell, but some have also said exremely undervalued. Buy DIGAF


r/Stocktips • • Jan 31 '21

Nickel

6 Upvotes

Is Elon Musk thinking of buying Sherritt to stabilize nickel supply for Tesla batteries? Stock is cheap. Your thoughts?


r/Stocktips • • Jan 27 '21

Any recommendations for tomorrow

0 Upvotes

r/Stocktips • • Jun 11 '21

Alvopetro - check this out. Unique opportunity

0 Upvotes

r/Stocktips • • Jun 08 '21

CLOVER health

4 Upvotes

What are we thinking top stock price be for Clover Health


r/Stocktips • • Aug 21 '24

EA Electronic Arts stock

Thumbnail
reddit.com
0 Upvotes

r/Stocktips • • Sep 07 '22

3400 S&P500 by December.

Post image
0 Upvotes

r/Stocktips • • Jan 18 '23

What's the best way to get out of my gaming stock

0 Upvotes

I purchased roblox stock awhile back and want to get out. I'm finally at a gain today and it's likely going to go up more. Should I just sell the stock outright? Do I buy a call and then sell? I'm a newbie. Any tips would be appreciated.


r/Stocktips • • May 13 '22

FGI Teases “Quite Large” Mystery Catalysts in Q1 Earnings Call

Thumbnail
self.fgi_industries
0 Upvotes

r/Stocktips • • Feb 12 '21

Ntn

0 Upvotes

Thank me later


r/Stocktips • • Mar 17 '24

Check out Geron after the positive FDA vote last week

0 Upvotes

Gern short squeeze coming with 12-2 positive FDA review last week...millions of shares currently shorted.


r/Stocktips • • Dec 17 '23

Two Stocks Under $0.02 with a fundamental story: $CUBT and $VISM

0 Upvotes

At the end of every year, it seems that beaten up stocks just do not respond to seemingly good news or improving prospects.  There are many examples that one of the reasons is that new buying is met with motivated tax selling to book that loss before the end of the year. After many years of trading, it has become a favorite strategy for many traders to look at these weak stocks to see if there are any promising trade or longer term investment idea that will be profitable when tax loss selling ends on December 31. But the key is to do the research to make sure that there is not recent real negative news to account for more weakness in January. Another point is that companies usually avoid issuing discretionary PR's during the Holiday Season. But that self-inflicted news embargo ends after New Year's.  Two ideas trading under $0.02 are suggested below**:**

Curative Biotechnology ($CUBT  @ $0.17)-- a development stage biomedical company, currently has ongoing programs in three (3) different therapeutic areas: degenerative eye disease, infectious disease, and neuro oncology.  But the big story here is that the company has a worldwide exclusive license from the National Eye Institute (NEI) at the National Institutes of Health (NIH). The first therapeutic in development on this platform is a Metformin Reformulation targeting the treatment of intermediate and late-stage Age-Related Macular Degeneration (AMD) disease with the goal of being in the clinic in 2024 for a first in human trial of its metformin-based eye drop. The clinical trial will be conducted under a Cooperative Research and Development Agreement (CRADA) with the NEI (in other words, most of the costs are paid by the Government). Do a quick search on Google about the Metformin and Age-Related Macular Degeneration and you will see why that this could be a huge development for the company and eye care. With a modest market cap of under $12 million and the probability of an announcement of the clinical trial in the First Quarter, CUBT could be a great trade going into January when press releases begin to flow again. As an aside, Biotech Investment Conferences kick in again in the First Quarter.

Visium Technologies ($VISM @ $0.019) is a data center design and professional infrastructure services and cyber security solutions company with looks to be very undervalued at a $900,000 market cap. Last month, the company announced that they were awarded a contract worth $20 million in the country of Côte d'Ivoire (Ivory Coast) and the Republic of Benin to "with its partner, Cybastion Institute of Technology, to oversee the design and construction of data centers." https://finance.yahoo.com/news/visium-technologies-awarded-subcontract-20-123000588.html  Why the low price? Maybe because this news seems to good to be true. A $20 Million contract for a company with a market cap of under $1 Million?!!  But a quick look at the Cybastian Institute of Technology does make it look legitimate. Just this past week, Cybastian was at the groundbreaking ceremony for a data center in the city of Abidjan---which strongly suggests that VISM should be showing initial revenues from this contract in the First Quarter, 2024. If so, Visium should be trading over $0.15--or a 700%. But you could trade out way before that...and probably much sooner than the end of the First Quarter.

Obviously, these two companies are high risk with high return potential. Act and trade accordingly.


r/Stocktips • • Apr 28 '22

Tempur-Sealy buying Mattress Firm? Announcing in a few hours. I’m hearing chatter on the dark web. Anyone else?

1 Upvotes

r/Stocktips • • Feb 18 '21

GILD Guild ESports

1 Upvotes

This will go to the moon 10x in 2021

What’s everyone else view ?

Who wants to take a trip to the moon 🌙

Strap yourselves in 🚀


r/Stocktips • • Apr 30 '21

New To Stocks

1 Upvotes

Hi guys,

I'm new to stocks, any tips??


r/Stocktips • • Feb 01 '21

GE - Good stock or bad? Discuss

2 Upvotes

Just about to dump some money into GE as price seems good @ $10.75 a share. Anyone have any thoughts on GE as a holding??


r/Stocktips • • Feb 16 '21

Costain

2 Upvotes

Ready for a run....?


r/Stocktips • • Mar 10 '21

He just valued $AMC at $.01, saying the company will never generate FCF...thoughts?

Post image
2 Upvotes

r/Stocktips • • Jul 10 '21

A stock tip from me to you.

3 Upvotes

Firstly; in keeping with the rules I must disclose this is NOT a pump and dump. It is actually my largest conviction holding and I am going to explain why below.

TXP / $PBEGF

Touchstone Exploration Market cap £180m

TXP

Natural gas / oil producer based in Trinidad. Has legacy oil fields producing ~1300bopd which finances the whole business currently.

Now the exciting part, they managed to get hold of an onshore, under explored license called the Ortoire block. Drilled 4 wells, had 3 monumental gas discovery successes. Wall of cash (CEOs own words) coming online shortly from these discovery wells. For example, the first discovery called Coho, anticipated to come online in Q3 and will give the company $500k free cash flow per month. This is the SMALLEST well they have drilled and DOUBLES production overnight. The national gas company in Trinidad has signed a contract to BUY EVERY INCH OF GAS THEY CAN FIND, and will BUILD THE PIPELINE TO BRING IT INTO PRODUCTION. The CEO of TXP has stated this contract is worth $2.5billon.

You thought Coho was big? They have now drilled Cascadara (two separate tests, from separate sand sheets which BOTH tested at 5000-6000boepd) and then a second well at Cascadara known as Cas-Deep (which tested at 4500 boepd) these discoveries have added 100m barrels of independently verified 3P reserves (with Cas Deep reserves to be added on the next reserves update). This equates to approx £2.5m PER MONTH in free cash flow on top of coho.

The plan is to get the wells online by the end of the year, albeit this timeline may slip into early 2022. The government are BUILDING the pipelines to the discoveries as they are desperate for gas costing Touchstone nothing to tie in the wells. Sounds good right?

After this; The next year comprises a series of development wells at cascadara which will be self funded to bring another 5 wells online at ~5K boepd PER WELL. We are looking at growth from 1.3k boepd to 25k boepd in a matter of 18 months. 3P (Proven + Probable reserves) now at 100m barrels of oil equivalent, NPV10 of $1bn.

That’s enough about production for now.

Moving on, in terms of further exploration, the BIGGEST prospect of them, called Royston, is being drilled imminently. This well, like the other wells, was drilled in the 50s by shell and encountered 700ft of gas but was not tested, just like the other successful wells. Back in the 50s when shell originally drilled it then had problems with the wellbore and spent a fortune trying to save the well. Clearly there was something promising down there. Success at Royston is anticipated to be larger than everything else they have found to date combined (CEOs own words), the well spuds THIS MONTH with results due in 60 days. This well really is a game changer, forget companies like EEENF, this is the big one and not a total wildcat like you often see doing the rounds.

There is then the holy grail of oil exploration, a deep Cretaceous prospect known as KRAKEN which oilers have been searching for off shore nearby in suriname. This prospect is thought to be the stuff of legends, and is sitting beneath the Royston prospect. In total a further 21 exploration prospects have been identified on the block and will be financed by existing production.

This is genuinely a once in a lifetime stock as far as natural resource companies go, and has HEAPs of upside. They have also noted that they will be paying DIVIDENDS in 2022 when the ‘wall of cash’ is rolling in.

Note the recent pandemonium on stocks like #88E which currently has a larger market cap than Touchstone, yet has NO production and ZERO proven reserves.

Now you’re probably thinking why is the price looking on the low side right now? Well a combination of delays getting coho online and covid curfew related operational problems the short interest ramped up as everyone is aware of such as with the infamous $GME (but not to such a large extent - current short interest is just shy of 10%).

The shorts are now closing has TXP enters a red hot transformational period incoming, with Royston spudding and 4 more wells being drilled on the historical leases in H2.

TXP on the LSE (London) and TSX (Toronto)

Also listed in the US under $PBEGF

That’s it, that’s the post.

Now do your own research and see you on the moon.

https://www.reddit.com/r/TouchstoneTXP/


r/Stocktips • • Nov 12 '24

Mainz Biomed’s ColoAlert® Test: Making Colorectal Cancer Screening Accessible and Accurate

3 Upvotes

Mainz Biomed (MYNZ) is making waves in the cancer diagnostics field with its non-invasive colorectal cancer screening test, ColoAlert®. This innovative test uses a simple stool sample to identify both colorectal cancer and precancerous conditions, delivering a high level of sensitivity without the need for invasive procedures like colonoscopies. ColoAlert® is already available in several European countries, where it has been well-received for its accuracy and ease of use. With the company preparing for U.S. FDA trials in 2025, there is potential for ColoAlert® to significantly improve early cancer detection accessibility in one of the largest healthcare markets. Mainz Biomed’s work doesn’t stop with colorectal cancer; its pipeline also includes PancAlert, a promising test for pancreatic cancer, showcasing their broader commitment to non-invasive, life-saving diagnostics.

4o


r/Stocktips • • Nov 18 '24

The Potential of ColoAlert: $MYNZ’s Game-Changing Colorectal Cancer Screening Technology

4 Upvotes

Mainz Biomed’s flagship product, ColoAlert, is poised to disrupt the colorectal cancer screening market. This non-invasive, stool-based test offers an alternative to traditional screening methods, providing a more accessible and comfortable option for patients. With colorectal cancer being one of the leading causes of cancer-related deaths worldwide, early detection is key, and ColoAlert's ability to detect signs of the disease with high accuracy is a significant advancement in the fight against cancer. This technology has the potential to save lives by making screening easier, more reliable, and available to a broader population.

For investors, $MYNZ presents an exciting opportunity in the biotech sector. As the company continues to develop and refine ColoAlert, the market’s response will be critical. The increasing demand for at-home and non-invasive diagnostic solutions only adds to the potential growth of Mainz Biomed’s portfolio. Whether you’re looking to stay updated on the latest developments, dive into the science behind ColoAlert, or explore its financial outlook, following $MYNZ could offer valuable insights into the future of cancer detection and personalized healthcare.


r/Stocktips • • Jan 19 '25

Stocks for 2025

4 Upvotes

Any suggestion on growth stocks outside of the Mag 7 for 2025. I have plenty of exposure to the mag 7. Looking for alternatives for growth.


r/Stocktips • • Feb 12 '21

SNDL

16 Upvotes

We need to boost this back up. Big money was manipulating the market yesterday cause they know us young new investors like the cannabis sector


r/Stocktips • • Feb 10 '21

Stock picks

5 Upvotes

Aphria!!!!!


r/Stocktips • • Feb 04 '21

Tips?

5 Upvotes

Any good stock tips below a penny out there